A detailed history of Group One Trading, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 15,610 shares of ABBV stock, worth $3.13 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
15,610
Previous 33,039 52.75%
Holding current value
$3.13 Million
Previous $6.02 Million 55.5%
% of portfolio
0.09%
Previous 0.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $2.7 Million - $3.15 Million
-17,429 Reduced 52.75%
15,610 $2.68 Million
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $5.28 Million - $6.02 Million
33,039 New
33,039 $6.02 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $4.85 Million - $5.69 Million
-56,443 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $5.82 Million - $7.79 Million
-79,339 Reduced 58.43%
56,443 $5.54 Million
Q1 2020

May 13, 2020

BUY
$64.5 - $97.79 $8.76 Million - $13.3 Million
135,782 New
135,782 $10.3 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $7.5 Million - $9.39 Million
-104,044 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $6.81 Million - $8.19 Million
-108,201 Reduced 50.98%
104,044 $7.88 Million
Q2 2019

Aug 09, 2019

BUY
$65.7 - $83.98 $11.8 Million - $15.1 Million
179,471 Added 547.6%
212,245 $15.4 Million
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $2.28 Million - $2.68 Million
29,560 Added 919.73%
32,774 $2.64 Million
Q4 2018

Feb 06, 2019

SELL
$77.85 - $96.01 $1.8 Million - $2.22 Million
-23,149 Reduced 87.81%
3,214 $296,000
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $4,623 - $5,139
52 Added 0.2%
26,363 $2.49 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $1.26 Million - $1.49 Million
-14,072 Reduced 34.85%
26,311 $2.44 Million
Q1 2018

May 11, 2018

BUY
$92.01 - $123.21 $3.72 Million - $4.98 Million
40,383 New
40,383 $3.82 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.